S&N US ortho prospects rosier than expected
This article was originally published in Clinica
Executive Summary
It seems Smith & Nephew may have had an overly pessimistic outlook of its orthopedics business, after a US surgeon survey by Morgan Stanley revealed that the company’s reconstructive implants – particularly its knee devices – are viewed more positively in the market than expected.